US Patent 9261509 Methods for monitoring methotrexate therapy

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9261509

Date of Patent

February 16, 2016

Patent Application Number

13810683

Date Filed

September 13, 2011

Patent Citations Received

‌

US Patent 12128046 Alpha polyglutamated methotrexate and uses thereof

‌

US Patent 12076402 Alpha polyglutamated antifolates and uses thereof

‌

US Patent 11701432 Polyglutamated antifolates and uses thereof

‌

US Patent 11771700 Gamma polyglutamated lometrexol and uses thereof

‌

US Patent 11779584 Alpha polyglutamated pemetrexed and uses thereof

Patent Primary Examiner

‌

Ralph Gitomer

Patent abstract

The present invention provides methods for assessing efficacy of a methotrexate (MTX) dosing regimen in a patient.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9261509 Methods for monitoring methotrexate therapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API